Phosphate dialysis fluid for continuous kidney dialysis
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special dialysis fluid that contains phosphate (a mineral) to see if it helps keep phosphate levels normal during continuous kidney dialysis (CRRT). It may be helpful for people who need this type of dialysis for several days in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to need continuous kidney dialysis (CRRT) for at least 72 hours.
- You must not have had any dialysis or blood cleaning in the 24 hours before joining.
- You cannot be pregnant or breastfeeding.
- You cannot be in another research study with an investigational drug or device right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding an iron chelator (MEX-CD1) to the dialysis fluid can help remove harmful iron from the blood in patients with sepsis-related acute kidney injury who need continuous dialysis. It may reduce damage to the kidneys and other organs.
This study compares two blood-thinning medications used during continuous dialysis for acute kidney injury: one uses citrate (a chemical that prevents clotting) and the other uses heparin (a standard blood thinner). By looking at how well these treatments work, the study aims to find the safest and most effective way to keep the dialysis filter working.
This study looks at how continuous renal replacement therapy (a type of dialysis) is used in intensive care unit (ICU) patients. Participation will help doctors understand how to better support kidney function in critically ill people.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This study compares two ways to prevent blood clots during kidney dialysis in people with sepsis-related kidney failure. The goal is to see which method is safer and works better to keep the dialysis filter working properly.
This study tests a new way to monitor patients while they receive continuous kidney replacement therapy (a type of dialysis) in the ICU. It aims to see if this monitoring can be done safely and smoothly, helping doctors track your treatment better.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.